Evidence to Use Botulinum Toxin Injections in Tension-Type Headache Management: A Systematic Review
AbstractTension-type headache (TTH) is the most common type of chronic recurring head pain. It can occur twice as often in women as in men. It is the most common type of headache. Its lifetime prevalence is 30% to 78% in the general population. TTH treatment should be multilevel. It often consists of taking pain medication, muscle relaxants, antidepressants, using biofeedback therapy, acupuncture, and attending behavioral therapy. Several clinical trials also suggest that botulinum toxin (BTX) may be an effective treatment option for such patients. The aim of this study was to evaluate if BTX can be used as a treatment method in TTH in the light of current medical literature. The authors searched the PubMed, EBSCOhost, OVID, Web of Knowledge, Cochrane Library and CINAHL databases to identify relevant publications. The authors finally included 11 papers—prospective and retrospective cohort studies. Among most of the selected studies, there was a significant correlation between using BTX and reduction of TTH pain intensity and severity. By analyzing qualified studies, it can be concluded that botulinum toxin seems to be effective in TTH management. View Full-Text
Share & Cite This Article
Wieckiewicz, M.; Grychowska, N.; Zietek, M.; Wieckiewicz, G.; Smardz, J. Evidence to Use Botulinum Toxin Injections in Tension-Type Headache Management: A Systematic Review. Toxins 2017, 9, 370.
Wieckiewicz M, Grychowska N, Zietek M, Wieckiewicz G, Smardz J. Evidence to Use Botulinum Toxin Injections in Tension-Type Headache Management: A Systematic Review. Toxins. 2017; 9(11):370.Chicago/Turabian Style
Wieckiewicz, Mieszko; Grychowska, Natalia; Zietek, Marek; Wieckiewicz, Gniewko; Smardz, Joanna. 2017. "Evidence to Use Botulinum Toxin Injections in Tension-Type Headache Management: A Systematic Review." Toxins 9, no. 11: 370.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.